PMID,Title,Journal,Year
35784742,"A Randomized Controlled Dose-Escalation Study of LY06006, a Recombinant Humanized Monoclonal Antibody to RANKL, in Chinese Healthy Adults.",Frontiers in pharmacology,2022
29337457,[Pharmacovigilance update].,Revue medicale suisse,2018
